BiotechTube
Integral BioSystems

Integral BioSystems

Medford, United States· Est.
integralbiosystems.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.5M

Overview

Integral BioSystems is a specialized contract research organization (CRO) with deep expertise in complex drug delivery and formulation development. Operating from a cGLP-compliant lab in Greater Boston, the company serves biopharmaceutical clients with services spanning pre-formulation, analytical development, scale-up, and toxicology supply manufacturing. Beyond fee-for-service work, Integral has developed proprietary, patent-protected delivery platforms (OcuHeal™ and NanoM Wafer™) available for licensing, positioning it as both a service provider and a technology enabler for 505(b)(2) drug repurposing.

Drug Delivery

Technology Platform

Proprietary drug delivery platforms OcuHeal™ and NanoM Wafer™ for 505(b)(2) products, plus broad expertise in sustained-release systems (microspheres, liposomes, hydrogels, nanocrystals).

Funding History

2
Total raised:$3.5M
Seed$3M
Grant$500K

Opportunities

Growing demand for CRO services specializing in complex formulations for new drug modalities (proteins, nucleic acids).
The 505(b)(2) regulatory pathway creates a niche for licensable delivery platforms that can extend the IP and commercial life of repurposed drugs.

Risk Factors

Revenue is tied to client R&D budgets, which are cyclical and sensitive to biotech funding environments.
Success of proprietary platforms depends on uncertain business development efforts to secure licensing partners.
High competition for talent and contracts in the Boston biotech hub.

Competitive Landscape

Operates in a highly competitive CRO market against large global players (e.g., Lonza, Catalent) and numerous niche specialists. Differentiates through deep expertise in complex/sustained-release formulations and a hybrid model offering licensable platform technologies.

More companies in United States →